These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 19758212

  • 1. Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease.
    Zandman-Goddard G, Berkun Y, Barzilai O, Boaz M, Blank M, Ram M, Sherer Y, Anaya JM, Shoenfeld Y.
    Ann N Y Acad Sci; 2009 Sep; 1173():658-63. PubMed ID: 19758212
    [Abstract] [Full Text] [Related]

  • 2. [Systemic lupus erythematosus and Epstein-Barr virus].
    Tazi I, Fehri S, Elghrari K, Ouazzani T, Benchemsi N.
    East Mediterr Health J; 2009 Sep; 15(3):701-8. PubMed ID: 19731786
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW, Myrmel H.
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [Abstract] [Full Text] [Related]

  • 4. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
    Chen CJ, Lin KH, Lin SC, Tsai WC, Yen JH, Chang SJ, Lu SN, Liu HW.
    J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
    [Abstract] [Full Text] [Related]

  • 5. Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile.
    Chougule D, Nadkar M, Rajadhyaksha A, Pandit-Shende P, Surve P, Dawkar N, Khadilkar P, Patwardhan M, Kaveri S, Ghosh K, Pradhan V.
    J Med Virol; 2018 Mar; 90(3):559-563. PubMed ID: 28734074
    [Abstract] [Full Text] [Related]

  • 6. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.
    Touge C, Agawa H, Sairenji T, Inoue Y.
    Arch Virol; 2006 May; 151(5):895-903. PubMed ID: 16362642
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
    Grandjean Lapierre S, Vallières E, Rabaamad L, Labrecque M, Chartrand C, Renaud C.
    J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036
    [Abstract] [Full Text] [Related]

  • 8. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
    Maylin S, Feghoul L, Salmona M, Herda A, Mercier-Delarue S, Simon F, Legoff J.
    J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
    [Abstract] [Full Text] [Related]

  • 9. Infectious antibodies in systemic lupus erythematosus patients.
    Berkun Y, Zandman-Goddard G, Barzilai O, Boaz M, Sherer Y, Larida B, Blank M, Anaya JM, Shoenfeld Y.
    Lupus; 2009 Nov; 18(13):1129-35. PubMed ID: 19880558
    [Abstract] [Full Text] [Related]

  • 10. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
    Farrell RA, Antony D, Wall GR, Clark DA, Fisniku L, Swanton J, Khaleeli Z, Schmierer K, Miller DH, Giovannoni G.
    Neurology; 2009 Jul 07; 73(1):32-8. PubMed ID: 19458321
    [Abstract] [Full Text] [Related]

  • 11. Reduced IgG anti-small nuclear ribonucleoprotein autoantibody production in systemic lupus erythematosus patients with positive IgM anti-cytomegalovirus antibodies.
    Palafox Sánchez CA, Satoh M, Chan EK, Carcamo WC, Muñoz Valle JF, Orozco Barocio G, Oregon Romero E, Navarro Hernández RE, Salazar Páramo M, Cabral Castañeda A, Vázquez Del Mercado M.
    Arthritis Res Ther; 2009 Jul 07; 11(1):R27. PubMed ID: 19232124
    [Abstract] [Full Text] [Related]

  • 12. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.
    Robertson P, Beynon S, Whybin R, Brennan C, Vollmer-Conna U, Hickie I, Lloyd A.
    J Med Virol; 2003 Aug 07; 70(4):617-23. PubMed ID: 12794726
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of a multiplexed bead assay for assessment of Epstein-Barr virus immunologic status.
    Klutts JS, Liao RS, Dunne WM, Gronowski AM.
    J Clin Microbiol; 2004 Nov 07; 42(11):4996-5000. PubMed ID: 15528686
    [Abstract] [Full Text] [Related]

  • 14. [Performance of the VIDAS automated immunoassay for the determination of Epstein-Barr virus serological status].
    De Ory F, Guisasola ME, Sanz JC, García-Bermejo I.
    Enferm Infecc Microbiol Clin; 2012 Dec 07; 30(10):618-20. PubMed ID: 22854635
    [Abstract] [Full Text] [Related]

  • 15. Humoral markers of active Epstein-Barr virus infection associate with anti-extractable nuclear antigen autoantibodies and plasma galectin-3 binding protein in systemic lupus erythematosus.
    Rasmussen NS, Nielsen CT, Houen G, Jacobsen S.
    Lupus; 2016 Dec 07; 25(14):1567-1576. PubMed ID: 27084029
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method.
    Corrales I, Giménez E, Navarro D.
    Clin Vaccine Immunol; 2014 May 07; 21(5):684-8. PubMed ID: 24623623
    [Abstract] [Full Text] [Related]

  • 17. Analytical performance evaluation of the Elecsys Epstein-Barr virus immunoassay panel.
    Schulte-Spechtel U, Berth M, Lauseker-Hao Y, Meyer-Schlinkmann K, Bohnert M, Jochum S, Schuhmann K.
    Diagn Microbiol Infect Dis; 2021 Nov 07; 101(3):115443. PubMed ID: 34304105
    [Abstract] [Full Text] [Related]

  • 18. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Us T, Cetin E, Kaşifoğlu N, Kaşifoğlu T, Akgün Y.
    Mikrobiyol Bul; 2011 Oct 07; 45(4):677-83. PubMed ID: 22090298
    [Abstract] [Full Text] [Related]

  • 19. Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study.
    Esen BA, Yılmaz G, Uzun S, Ozdamar M, Aksözek A, Kamalı S, Türkoğlu S, Gül A, Ocal L, Aral O, Inanç M.
    Rheumatol Int; 2012 Jan 07; 32(1):79-83. PubMed ID: 20661740
    [Abstract] [Full Text] [Related]

  • 20. Epstein-Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity.
    Aygun D, Kuskucu MA, Sahin S, Adrovic A, Barut K, Yıldız M, Sharifova S, Midilli K, Cokugras H, Camcıoglu Y, Kasapcopur O.
    Lupus; 2020 Sep 07; 29(10):1263-1269. PubMed ID: 32646294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.